Cerebral cavernous malformation (CCM) patients treated with oral drug, REC-994, showed reduction in total cerebral and brainstem lesion volume.

The FDA’s framework for AI regulation, while robust for premarket evaluation, would benefit from more specific mechanisms for continuous monitoring of AI performance in diverse real-world settings.

The words “artificial intelligence” are now ubiquitous, their influence having risen dramatically in recent years and their ...

Medtech company DermaSensor has claimed FDA approval for a handheld device ... that measures the physical properties of tissue with an AI algorithm to interpret the data. It can deliver a result ...

Chief R&D and commercial officer Najat Khan, PhD, tells GEN Edge the company aims to improve design of studies, accelerate enrollment, and enhance evidence generation.

FY25 Blinklab initiated an FDA registrational study of its Dx 1 platform as an aid in autism diagnosis, plus more biotech ...

The year is 2030, you have been in the doctor's office for two hours, answering what seems like hundreds of questions on ...

Pune, Jan. 31, 2025 (GLOBE NEWSWIRE) -- Portable Ultrasound Market Size & Growth Analysis: According to SNS Insider, the global Portable Ultrasound Market size was valued at USD 2.6 billion in 2023 ...

The eyes, often called the windows to the soul, have become a powerful tool for unlocking transformative health insights.

Smart watches, rings, and a growing array of patches are adding more functionality and being used across a growing set of ...

Brisbane, Australia-based ResApp has claimed a 510(k ... seeking ownership of a portfolio of apps that use artificial intelligence algorithms to both diagnose and measure the severity of ...